VXRT vs. ALB
VXRT (Vaxart, Inc.) and ALB (Albemarle Corporation) are both stocks. VXRT operates in Biotechnology (Healthcare), while ALB operates in Specialty Chemicals (Basic Materials). Over the past 5 years, VXRT returned -42.59%/yr vs -0.83%/yr for ALB. At a 0.21 correlation, their price movements are largely independent.
Performance
VXRT vs. ALB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VXRT achieves a 49.80% return, which is significantly higher than ALB's 6.57% return.
VXRT
- 1D
- -3.01%
- 1M
- -19.52%
- YTD
- 49.80%
- 6M
- 45.55%
- 1Y
- -7.41%
- 3Y*
- -16.10%
- 5Y*
- -42.59%
- 10Y*
- —
ALB
- 1D
- -4.28%
- 1M
- -12.37%
- YTD
- 6.57%
- 6M
- 2.75%
- 1Y
- 162.90%
- 3Y*
- -10.65%
- 5Y*
- -0.83%
- 10Y*
- 8.06%
VXRT vs. ALB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
VXRT Vaxart, Inc. | 49.80% | -47.68% | 15.59% | -40.39% | -84.67% | 9.81% | 1,529.10% | -81.36% | -78.09% |
ALB Albemarle Corporation | 6.57% | 67.72% | -39.50% | -32.80% | -6.63% | 59.76% | 105.39% | -3.28% | -27.45% |
Correlation
The correlation between VXRT and ALB is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Feb 12, 2018 | 0.22 |
The correlation between VXRT and ALB shifts across timeframes, from 0.03 (1 year) to 0.26 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
VXRT:
$125.67M
ALB:
$17.79B
VXRT:
$0.16
ALB:
-$2.33
VXRT:
0.47
ALB:
3.22
VXRT:
1.34
ALB:
2.34
VXRT:
$255.61M
ALB:
$5.49B
VXRT:
$193.63M
ALB:
$1.02B
VXRT:
$45.63M
ALB:
$801.97M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VXRT vs. ALB — Risk / Return Rank
VXRT
ALB
VXRT vs. ALB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vaxart, Inc. (VXRT) and Albemarle Corporation (ALB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VXRT | ALB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.69 | ||
| Sortino ratioReturn per unit of downside risk | -2.23 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.36 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.16 | 5.17 | -5.33 |
| Martin ratioReturn relative to average drawdown | -0.27 | 14.71 | -14.98 |
Loading charts...
Drawdowns
VXRT vs. ALB - Drawdown Comparison
The maximum VXRT drawdown since its inception was -98.71%, which is greater than ALB's maximum drawdown of -83.90%. Use the drawdown chart below to compare losses from any high point for VXRT and ALB.
Loading charts...
Drawdown Indicators
| VXRT | ALB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.71% | -83.90% | -14.81% |
Max Drawdown (1Y)Largest decline over 1 year | -46.43% | -31.72% | -14.71% |
Max Drawdown (3Y)Largest decline over 3 years | -78.72% | -78.60% | -0.12% |
Max Drawdown (5Y)Largest decline over 5 years | -96.94% | -83.90% | -13.04% |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.90% | — |
Current DrawdownCurrent decline from peak | -97.78% | -51.48% | -46.30% |
Average DrawdownAverage peak-to-trough decline | -82.98% | -20.70% | -62.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 27.88% | 11.12% | +16.76% |
Volatility
VXRT vs. ALB - Volatility Comparison
The current volatility for Vaxart, Inc. (VXRT) is 11.63%, while Albemarle Corporation (ALB) has a volatility of 15.91%. This indicates that VXRT experiences smaller price fluctuations and is considered to be less risky than ALB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VXRT | ALB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.63% | 15.91% | -4.28% |
Volatility (6M)Calculated over the trailing 6-month period | 76.96% | 42.88% | +34.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 97.70% | 62.62% | +35.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 92.41% | 54.72% | +37.69% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 128.49% | 48.36% | +80.13% |
Dividends
VXRT vs. ALB - Dividend Comparison
VXRT has not paid dividends to shareholders, while ALB's dividend yield for the trailing twelve months is around 1.08%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALB Albemarle Corporation | 1.08% | 1.15% | 1.87% | 1.11% | 0.73% | 0.67% | 1.04% | 2.01% | 1.74% | 1.00% | 1.42% | 2.07% |
VXRT Vaxart, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
VXRT vs. ALB - Financials Comparison
This section allows you to compare key financial metrics between Vaxart, Inc. and Albemarle Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VXRT vs. ALB - Profitability Comparison
VXRT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vaxart, Inc. reported a gross profit of 0.00 and revenue of 39.23M. Therefore, the gross margin over that period was 0.0%.
ALB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Albemarle Corporation reported a gross profit of 500.97M and revenue of 1.43B. Therefore, the gross margin over that period was 35.1%.
VXRT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vaxart, Inc. reported an operating income of 5.17M and revenue of 39.23M, resulting in an operating margin of 13.2%.
ALB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Albemarle Corporation reported an operating income of 233.51M and revenue of 1.43B, resulting in an operating margin of 16.3%.
VXRT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vaxart, Inc. reported a net income of 5.18M and revenue of 39.23M, resulting in a net margin of 13.2%.
ALB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Albemarle Corporation reported a net income of 277.40M and revenue of 1.43B, resulting in a net margin of 19.4%.
Frequently Asked Questions
VXRT and ALB have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ALB has higher volatility (15.91%) compared to VXRT (11.63%). In terms of maximum drawdown, VXRT dropped -98.71% vs ALB's -83.90%.
ALB currently has the higher Sharpe Ratio (2.62 vs -0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VXRT and ALB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer